Drugs for Treatment of Hyperkalemia and Hyperphosphatemia
- Drugs for Treatment of Hyperkalemia and Hyperphosphatemia
- Accession Number
- Not Available
- ATC Classification
Drug Drug Description Calcium acetate A phosphate binder used in patients with end-stage renal disease (ESRD) to prevent elevated phosphate levels and resulting ectopic calcification and secondary hyperparathyroidism. Sevelamer A phosphate binder used to treat hyperphosphatemia. Tolevamer A potassium-binding resin used in the treatment of hyperkalemia. Lanthanum carbonate A phosphate binder indicated for the reduction of serum phosphate in patients with end stage renal disease. Iron sucrose An compound used as a source of iron in patients with iron deficiency anemia associated with chronic kidney disease (CKD). Colestilan chloride Colestilan is an ingredient in the EMA-withdrawn product BindRen. Magnesium carbonate An antacid used for symptomatic relief of heartburn, indigestion, and upset stomach. Tetraferric tricitrate decahydrate A phosphate binder used to control serum phosphorus levels or as an iron supplement. Sodium zirconium cyclosilicate A potassium binder used to treat hyperkalemia.
- Drugs & Drug Targets